FI933253A0 - Nya amylinantagonistpeptider och anvaendning som amylinantagonister - Google Patents
Nya amylinantagonistpeptider och anvaendning som amylinantagonisterInfo
- Publication number
- FI933253A0 FI933253A0 FI933253A FI933253A FI933253A0 FI 933253 A0 FI933253 A0 FI 933253A0 FI 933253 A FI933253 A FI 933253A FI 933253 A FI933253 A FI 933253A FI 933253 A0 FI933253 A0 FI 933253A0
- Authority
- FI
- Finland
- Prior art keywords
- amylinantagonistpeptider
- amylinantagonister
- nya
- och anvaendning
- anvaendning som
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- C07K14/575—Hormones
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
- A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Organic Chemistry (AREA)
- Diabetes (AREA)
- General Health & Medical Sciences (AREA)
- Endocrinology (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Veterinary Medicine (AREA)
- General Chemical & Material Sciences (AREA)
- Obesity (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Hematology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Engineering & Computer Science (AREA)
- Animal Behavior & Ethology (AREA)
- Emergency Medicine (AREA)
- Public Health (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Toxicology (AREA)
- Zoology (AREA)
- Gastroenterology & Hepatology (AREA)
- Biochemistry (AREA)
- Biophysics (AREA)
- Genetics & Genomics (AREA)
- Molecular Biology (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Peptides Or Proteins (AREA)
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US07/794,288 US5580953A (en) | 1991-08-14 | 1991-11-19 | Amylin antagonist peptides and uses therefor |
PCT/US1992/010011 WO1993010147A1 (en) | 1991-11-19 | 1992-11-19 | Novel amylin antagonist peptides and uses therefor |
Publications (2)
Publication Number | Publication Date |
---|---|
FI933253A0 true FI933253A0 (fi) | 1993-07-16 |
FI933253A FI933253A (fi) | 1993-09-08 |
Family
ID=25162237
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
FI933253A FI933253A (fi) | 1991-11-19 | 1993-07-16 | Nya amylinantagonistpeptider och anvaendning som amylinantagonister |
Country Status (10)
Country | Link |
---|---|
US (1) | US5580953A (fi) |
EP (1) | EP0568687A1 (fi) |
JP (1) | JPH06504795A (fi) |
AU (1) | AU672589B2 (fi) |
CA (1) | CA2100743A1 (fi) |
CZ (1) | CZ168893A3 (fi) |
FI (1) | FI933253A (fi) |
SG (1) | SG44826A1 (fi) |
SK (1) | SK88893A3 (fi) |
WO (1) | WO1993010147A1 (fi) |
Families Citing this family (29)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
HU222249B1 (hu) * | 1991-03-08 | 2003-05-28 | Amylin Pharmaceuticals Inc. | Eljárás amilin agonista peptidszármazékok és ezeket tartalmazó gyógyszerkészítmények előállítására |
AU6249594A (en) * | 1993-02-12 | 1994-08-29 | Amylin Pharmaceuticals, Inc. | Mcf-7 binding site assays |
AU669636B2 (en) * | 1993-05-12 | 1996-06-13 | University Of Cincinnati, The | Amylin antagonists and agonists |
US5625032A (en) * | 1993-07-21 | 1997-04-29 | Amylin Pharmaceuticals, Inc. | Selective amylin antagonist peptides and uses therefor |
CZ69596A3 (en) * | 1993-09-07 | 1997-06-11 | Amylin Pharmaceuticals Inc | Application of amylin, amylin agonist, amylin analog agonist or amylin antagonist for preparing a pharmaceutical preparation used for the control of gastrointestinal motility |
US5739106A (en) * | 1995-06-07 | 1998-04-14 | Rink; Timothy J. | Appetite regulating compositions |
AU766653B2 (en) | 1998-02-13 | 2003-10-23 | Amylin Pharmaceuticals, Inc. | Novel mixed amylin activity compounds |
US6936584B1 (en) | 1998-02-13 | 2005-08-30 | Amylin Pharmaceuticals, Inc. | Mixed amylin activity compounds |
US6268474B1 (en) | 1998-04-30 | 2001-07-31 | Creighton University | Peptide antagonists of CGRP-receptor superfamily and methods of use |
AU2001230587A1 (en) * | 2000-02-18 | 2001-08-27 | Sumitomo Pharmaceuticals Company, Limited | Drugs for ameliorating impaired glucose tolerance |
JP2004532896A (ja) * | 2001-06-22 | 2004-10-28 | ザ ユニバーシティ オブ ブリティッシュ コロンビア | I型糖尿病の診断及び治療 |
US20070129307A1 (en) * | 2001-06-22 | 2007-06-07 | The University Of British Columbia | Insulin epitopes for the treatment of type 1 diabetes |
AU2003264256A1 (en) * | 2002-09-04 | 2004-03-29 | Dsm Ip Assets B.V. | A nutritional and therapeutic composition of an insulin sensitizer and a peptide fraction |
US7279971B2 (en) | 2002-09-06 | 2007-10-09 | Telefonaktiebolaget Lm Ericsson (Publ) | Composite power amplifier |
US8008255B2 (en) | 2003-05-30 | 2011-08-30 | Amylin Pharmaceuticals, Inc. | Methods and compositions for enhanced transmucosal delivery of peptides and proteins |
US20070275877A1 (en) * | 2003-08-29 | 2007-11-29 | Amylin Pharmaceuticals, Inc. | Methods for Treating or Ameliorating Ghrelin-Associated Diseases and Disorders |
WO2006083254A1 (en) * | 2004-02-11 | 2006-08-10 | Amylin Pharmaceuticals, Inc. | Amylin family peptides and methods for making and using them |
US7399744B2 (en) * | 2004-03-04 | 2008-07-15 | Amylin Pharmaceuticals, Inc. | Methods for affecting body composition |
US20090069226A1 (en) * | 2004-05-28 | 2009-03-12 | Amylin Pharmaceuticals, Inc. | Transmucosal delivery of peptides and proteins |
DE102004051014A1 (de) * | 2004-10-20 | 2006-04-27 | Rwth Aachen | Chemisch modifizierte Peptidanaloga |
MX2007004892A (es) | 2004-10-27 | 2007-08-16 | Scripps Research Inst | Componentes de traduccion ortogonales para la incorporacion in vivo de aminoacidos no naturales. |
EP2286837A3 (en) | 2004-11-01 | 2013-09-04 | Amylin Pharmaceuticals, LLC | Treatment of obesity and obesity related diseases |
US8394765B2 (en) * | 2004-11-01 | 2013-03-12 | Amylin Pharmaceuticals Llc | Methods of treating obesity with two different anti-obesity agents |
US8168592B2 (en) | 2005-10-21 | 2012-05-01 | Amgen Inc. | CGRP peptide antagonists and conjugates |
CN101400698A (zh) | 2006-03-15 | 2009-04-01 | 诺沃-诺迪斯克有限公司 | 胰岛淀粉样多肽衍生物 |
CN101939022A (zh) * | 2007-11-14 | 2011-01-05 | 安米林药品公司 | 治疗肥胖以及肥胖相关疾病和病症的方法 |
EP2340261B1 (en) | 2008-10-21 | 2017-12-20 | Novo Nordisk A/S | Amylin derivatives |
AU2010206614B2 (en) * | 2009-01-22 | 2015-03-26 | Keybioscience Ag | Treatment for obesity |
CA2967616A1 (en) * | 2016-09-19 | 2018-03-19 | The Governors Of The University Of Alberta | Brain penetrant amylin receptor based peptides for alzheimer's disease |
Family Cites Families (7)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US3941763A (en) * | 1975-03-28 | 1976-03-02 | American Home Products Corporation | PGlu-D-Met-Trp-Ser-Tyr-D-Ala-Leu-Arg-Pro-Gly-NH2 and intermediates |
GB8720115D0 (en) * | 1987-08-26 | 1987-09-30 | Cooper G J S | Treatment of diabetes mellitus |
DE68924372T2 (de) * | 1988-01-11 | 1996-05-09 | Amylin Pharmaceuticals Inc | Behandlung von diabetes mellitus typ 2. |
US5266561A (en) * | 1988-01-11 | 1993-11-30 | Amylin Pharmaceuticals, Inc. | Treatment of type 2 diabetes mellitus |
DE69022501T2 (de) * | 1989-07-10 | 1996-02-01 | Amylin Pharmaceuticals Inc | Verwendung eines Amylinantagonisten zur Herstellung eines Artzneimittels zur Behandlung von Fettsucht und essentieller Hypertonie und damit zusammenhängenden Krankheiten. |
US5175146A (en) * | 1989-12-05 | 1992-12-29 | Vical, Inc. | Synthetic calcitonin peptides |
US5264372A (en) * | 1991-03-15 | 1993-11-23 | Amylin Pharmaceuticals, Inc. | Receptor-based screening methods for amylin agonists and antagonists |
-
1991
- 1991-11-19 US US07/794,288 patent/US5580953A/en not_active Expired - Lifetime
-
1992
- 1992-11-19 SK SK888-93A patent/SK88893A3/sk unknown
- 1992-11-19 CZ CS931688A patent/CZ168893A3/cs unknown
- 1992-11-19 JP JP5509532A patent/JPH06504795A/ja active Pending
- 1992-11-19 AU AU31431/93A patent/AU672589B2/en not_active Expired
- 1992-11-19 SG SG1996008299A patent/SG44826A1/en unknown
- 1992-11-19 WO PCT/US1992/010011 patent/WO1993010147A1/en not_active Application Discontinuation
- 1992-11-19 CA CA002100743A patent/CA2100743A1/en not_active Abandoned
- 1992-11-19 EP EP92925341A patent/EP0568687A1/en not_active Withdrawn
-
1993
- 1993-07-16 FI FI933253A patent/FI933253A/fi not_active Application Discontinuation
Also Published As
Publication number | Publication date |
---|---|
SK88893A3 (en) | 1994-03-09 |
EP0568687A1 (en) | 1993-11-10 |
AU672589B2 (en) | 1996-10-10 |
WO1993010147A1 (en) | 1993-05-27 |
SG44826A1 (en) | 1997-12-19 |
CA2100743A1 (en) | 1993-05-20 |
US5580953A (en) | 1996-12-03 |
JPH06504795A (ja) | 1994-06-02 |
AU3143193A (en) | 1993-06-15 |
FI933253A (fi) | 1993-09-08 |
CZ168893A3 (en) | 1994-04-13 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
FI933253A (fi) | Nya amylinantagonistpeptider och anvaendning som amylinantagonister | |
FI922735A (fi) | Nya behaollarsystem och vattenhaltiga kompositioner | |
FI921952A (fi) | Foerfarande foer framstaellning av dialkylenpiperidinofoereningar och enantiomerer daerav anvaendbara som laekemedel | |
FI924557A0 (fi) | Nya fenylpyrazolfungicider | |
FI934373A (fi) | Fabrikationsprocess av komposittraod och kompositprodukter som faotts avnaemnda traoden | |
FI924077A (fi) | Nya omaettade acykliska purin- och pyrimidinfosfonatderivat | |
FI921135A (fi) | Nya karbonsyraamider | |
FI933451A (fi) | Nya steroidestrar | |
FI925174A0 (fi) | Nya organokiselfoereningar och kompositioner innehaollande dem | |
FI933450A0 (fi) | Nya steroider | |
FI923756A (fi) | Polyolefinkompositioner som omfattar glycerolmonoestrar av c20-24-fettsyror och daerav framstaellda skumprodukter | |
FI925946A (fi) | Nya 2-sackarinylmetylaryl- och -aryloxiacetat anvaendbara som inhibitorer foer proteolytiska ensymer, kompositioner innehaollande dessa och anvaendning av dessa | |
FI906334A (fi) | Nya e-vitaminderivat och foerfarande foer framstaellning daerav. | |
FI925086A0 (fi) | Nya hybrid-vaextfaktorer | |
FI921614A (fi) | Nya herbicider | |
FI923872A (fi) | Nya bensopyranderivat | |
FI921596A (fi) | Tetron- och tiotetronsyraderivat och fosfolifas a2 som inhibitorer | |
FI930293A (fi) | Nya heteroaryloxi-b-karboliner, deras framstaellning och anvaendning i laekemedel | |
FI922472A (fi) | Gingerol- och gingerdiolderivat som hypokolesterolemiska och antiaterosklerostiska medel | |
FI922552A (fi) | Nya kefemfoereningar | |
FI934574A0 (fi) | Nya mikroorganismer och nya enzymer | |
FI923304A (fi) | Nya bearbetbara tiofenbaserade polymerer och kopolymerer, och vaermestabila elledande kompositioner daerav | |
FI924986A0 (fi) | Nya dietylentriaminderivat och anvaendning av dessa foer diagnostiska och terapeutiska aendamaol | |
FI925722A (fi) | Nya tiazoler | |
FI924883A0 (fi) | Nya alkaloider och foerfaranden foer produktion daerav |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
FD | Application lapsed |